Scion Accuses Abbott Of Misappropriating Clo-Sur Wound Dressing Secrets
This article was originally published in The Gray Sheet
Executive Summary
Scion Cardio-Vascular, Inc. is accusing Abbott Laboratories of lifting elements of its Clo-Sur P.A.D. marketing campaign, among other infractions, in a six-count complaint filed Nov. 22 in Miami federal court
You may also be interested in...
Scion v. Abbott
Scion Cardio-Vascular drops suit accusing Abbott of misappropriating Clo-Sur P.A.D. wound dressing trade secrets. The firm says it will conserve resources for marketing efforts (1"The Gray Sheet" Dec. 9, 2002, p. 18)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.